AI assistant
ENDRA Life Sciences Inc. — Director's Dealing 2018
Oct 24, 2018
35444_dirs_2018-10-24_3f02c436-6393-4e89-975a-585746693506.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ENDRA Life Sciences Inc. (NDRA)
CIK: 0001681682
Period of Report: 2018-10-22
Reporting Person: Longboard Capital Advisors, LLC (10% Owner)
Reporting Person: Conrad Brett (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-10-22 | Common Stock | S | 50200 | $4.1649 | Disposed | 379237 | Indirect |
| 2018-10-23 | Common Stock | S | 50000 | $4.2177 | Disposed | 329237 | Indirect |
| 2018-10-24 | Common Stock | S | 30000 | $4.1761 | Disposed | 299237 | Indirect |
Footnotes
F1: Longboard Capital Advisors, LLC is the Investment Manager of Grayboard Investments, Ltd. Grayboard Investments Ltd. sold 100,200 shares of Common Stock in Endra Life Sciences, Inc. Grayboard Investments, Ltd. now owns 110,338 shares of Common Stock in Endra Life Sciences, Inc.
F2: Longboard Capital Advisors, LLC is the General Partner of Blue Earth Fund, LP. Blue Earth Fund, LP sold 30,000 shares of Common Stock in Endra Life Sciences, Inc. Blue Earth Fund, LP now owns 188,899 shares of Common Stock in Endra Life Sciences, Inc. The total amount of Common Stock owned by Blue Earth Fund, LP is Grayboard Investments, Ltd. and Blue Earth Fund, LP is 299, 237. There was no change in the amount of Warrants to purchase Common Stock as previously reported.